Company’s $25,000 contributions to health-focused non-profits will support its Public Benefit Purpose
HINGHAM, MA, DECEMBER 16, 2020 — Sunflower Therapeutics, a public benefit corporation focused on efficient manufacturing for proteins, announced that it has donated $25,000 of its profits earned in 2020 to four non-profit organizations focused on serving the global poor. Donations were made to help enable the continued building and equipping of life-saving healthcare infrastructure worldwide. The beneficiary organizations, who were selected by Sunflower staff, will use this money to directly support the distribution of vaccines, the administration of COVID-related disease relief, and care for mothers and infants in vulnerable regions through improved medical care and nutrition.
“Sunflower is deeply honored by this opportunity to share a portion of our profits this year and support our Public Benefit Purpose to increase the global accessibility of health and wellness products”, said Sunflower’s Chief Executive Officer Dr. Kerry R. Love. “We believe that supporting underserved populations in this small way is a meaningful reaffirmation of our corporate values that include wellness, equity, and community.”
About Sunflower Therapeutics
Sunflower Therapeutics, PBC is a unique biotech company with a mission to enable more medicines to reach patients worldwide. Our goal is to transform access to biologic medicines for patients worldwide by creating novel technologies for development and manufacturing with the whole global community in mind. Using our core technologies–an efficient host, data-driven methods for process development, and novel manufacturing facilities–our team aims to create efficient, fast and less costly cycles of development and production for many new innovative patient-focused products. Sunflower’s research labs are currently located at LabCentral in Cambridge, Massachusetts.
Contact:
Sunflower Therapeutics PBC
Kerry R. Love
CEO/President
info@sunflowertx.com